Author

Andreas N. WICKI

University of ZurichORCID 0000-0002-2924-8080Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Viktor Hendrik KoelzeriD· 2 shared Alexander RingiD· 1 shared Ana GvozdenoviciD· 1 shared Berend SnijderiD· 1 shared Bettina SobottkaiD· 1 shared Burkhard BecheriD· 1 shared Cassandra LitchfieldiD· 1 shared Cinzia EspositoiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Viktor Hendrik KoelzerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 13, 2026

An RFX-driven ciliogenic cell state defines ex vivo FGFR-inhibitor sensitivity in colorectal cancer

Lucie Kralickova, Nicola Miglino, Cinzia Esposito…·Berend Snijder

The paper identifies an RFX-driven ciliogenic cell state in colorectal cancer that is sensitive to FGFR inhibitors and associated with poor prognosis.

DOI 10.64898/2026.10.12.756637

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCancer DiscoveryPeer-reviewedSep 22, 2026

Charting the liver and lung metastatic niche in breast cancer

Magdalena K. Sznurkowska, Francesc Castro-Giner, Irene D'Anna…·Nicola Aceto

The paper identifies differences in liver and lung metastatic niches in breast cancer, showing liver promotes metastasis while lungs inhibit it, and highlights BMP2-producing endothelial cells in the liver as key players.

DOI 10.1158/2159-8290.cd-25-1652

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintSep 17, 2025

RIPPLET: Mutation-Only Gene and Pathway Profiling for Precision Oncology

Fabius Wiesmann, Cassandra Litchfield, Maud Mayoux…·Bettina Sobottka

RIPPLET converts somatic DNA variants into gene-impact scores and pathway-perturbation profiles, outperforming multi-omic tools in identifying cancer drivers and predicting drug response without RNA data.

DOI 10.1101/2025.09.17.676675

humanwhole-genome sequencing

𝕏 PostBluesky